Decisions made in critical care are often complicated, requiring an in-depth understanding of the relations between complex diseases, available interventions, and patients with a wide range of characteristics. Standard modeling techniques such as decision trees and statistical modeling have difficulty in capturing these interactions as the complexity of the problem increases.
Introduction
Simulation is a general technique that uses mathematics to mimic, or simulate, the operations of a real-world process. The process under analysis is called a system, and the set of mathematical and logical assumptions made to describe how it works is called a model. The purpose of any simulation model is to determine the expected outputs of a model in the context of a hypothetical set of inputs. For example, a set of predictions from a statistical model such as a logistic regression would constitute a statistical simulation. Multiple predictions from a decision model or the determination of outcomes in a hypothetical population of patients are called cohort simulation, which is the most common method of evaluation for complex state-transition models. The basic method is to follow a hypothetical cohort throughout a given time period, keeping track of various events and outcomes that occur in various portions of the cohort. The Coronary Heart Disease Policy Model is an example of a frequently used, complex cohort simulation model in cardiovascular health services research [1] .
In the following, we discuss three common simulation methods, Markov modeling, Monte Carlo simulation, and discrete-event simulation (DES), providing specific examples of each from the critical care literature. For an in-depth review of these and other simulation techniques as they relate to health care decision-making, the reader is referred elsewhere [2] .
Markov modeling
One of the most common structures used in health care simulation modeling is the Markov model, also known as a Markov Process. Markov models require that all the relevant conditions in a particular problem be represented as a series of states. The set of states must be mutually exclusive (a patient can be in only one state at a time) and collectively exhaustive (the patient has to be in one of the states at all times). Patients (or portions of an entire cohort of patients) move through the model according to probabilities that govern how likely it is to transition from one state to another. An excellent review of the use of Markov models is found in Sonnenberg and Beck [3] .
Bauerle et al. [4] used a Markov model to describe the clinical course of sepsis in critically ill patients. They considered three states: well, septic, and dead. These states, together with data indicating the probability of transitioning from one state to another (called the transition probabilities), defined their Markov model. They described in detail the procedure used to develop the transition probabilities used in the model. In addition, they discussed how to use clinical data to define the individual patient cohorts. To run the Markov model, individual patient cohorts cycle through the different states of the model based on the transition probabilities. After each cycle, a new distribution of patients exists in each state. The system is run either for a fixed number of cycles or until all patients have entered an absorbing state (a state that they will remain in for all future cycles). The final distribution obtained at the end of the simulation allows for the calculation of useful information about the initial patient cohorts. In the Bauerle model, age-and gender-specific survival rates were compared, showing the difference in life expectancy compared with an average untreated standard population. The authors then used the model to develop mortality risk profiles associated with these different groups of patients.
Monte Carlo simulation
Monte Carlo simulation, a type of cohort simulation in which individual patients in the model are tracked over time, has been used to allow models to incorporate significantly more clinical complexity than standard Markovian cohort simulations. Examples of clinically important Monte Carlo simulations include models of heart disease, HIV infection, and stroke [1, [5] [6] [7] [8] [9] . Monte Carlo models are also an effective method to incorporate uncertainty into a cost-effectiveness analysis, an increasingly common technique used to evaluate expensive diagnostic and therapeutic strategies and technologies. The increasing popularity of simulation and costeffectiveness analysis is due in part to the high cost of caring for critically ill patients, which has put pressure on intensive care medicine to perform high-quality outcomes research to allow for informed decisions regarding the application of resources to various intensive care therapies [10, 11] .
Sébille and Valleron [12] used a Monte Carlo simulation model to describe the spread of antibiotic-resistant bacteria in an intensive care unit. Clinical and epidemiologic characteristics were specified to separately describe individual patients and staff members in the model. Individuals were allowed to interact with each other directly (staff members) or indirectly (patients interacting with one another through contact with the same staff member). Through a series of logical steps based on these interactions, each individual in the simulation could become colonized and therefore be infectious to others. The simulation was run in day increments for 2 years. Patient admissions and discharges from the unit depended on the individually specified patient's length of stay. Interactions between staff and patients directly affected transmission of bacteria, which was proportional to hand washing by the staff. The antibiotic treatment strategy specified in the model affected the rate of decolonization and clearance within infected individuals. By testing various antibiotic strategies and infection control measures, such as hand washing, one could compare the changes in the spread of infection. In doing so, Sé-bille and Valleron [12] demonstrated that such a model was useful in determining the best procedures to be used within an intensive care unit to minimize the spread of antibiotic-resistant bacteria.
Discrete-event simulation
Discrete-event simulation is a tool commonly found in industrial engineering and the management sciences. A DES model simulates the changing components of a system, enabling one to model the competition of resources and the resulting queues. Consider the problem of determining the number of beds needed in a critical care unit. Purchasing additional beds to test whether they could improve quality of care may be extremely expensive if they are not needed, whereas too few beds may have a negative impact on patient mortality. Similarly, in the determination of how to allocate organs for transplantation, implementing a nonoptimal policy may result in many wasted organs, drastically affecting the lives of many patients waiting for transplantation. Simulation provides an inexpensive, practical way to analyze changes to these systems without making risky changes to the real process.
Costa et al. [13•] developed a DES model to simulate the flow of individual patients through a single critical care unit. In their model, patients arriving at the critical care unit are first determined to be either elective or emergent, and priority status is then assigned to emergent patients, if desired. Based on bed availability, patients are admitted to the unit and assigned to available beds on a first-come first-serve basis, with higher-priority patients being assigned first. If a bed is not available, a patient can be transferred to another hospital or nursed elsewhere within the same hospital. Once a patient is assigned to a bed, the patient's expected length of stay is then determined based on patient-specific demographic and clinical information. A patient's time of departure can then be calculated based on the patient's arrival time and assigned length of stay.
In this model, the state of the system can be fully described by the number of beds in the critical care unit and the arrival time and length of stay of the patients assigned to each bed in the unit. Practically speaking, the system components do not continuously change over time. Rather, changes occur only after specific events happen. There are two possible events: a patient's arrival at the unit and a patient's departure from the unit. It is easy to see that between patients' arrivals and departures, the system does not change.
Because of its event-driven nature, a DES model can be broken down into the following components: entities, attributes, (global) variables, resources, queues, events, and statistical accumulators. Entities are the dynamic objects in the system. In the above model, the entities are the patients arriving at, entering, and departing from the unit. Attributes are entity-specific characteristics. The value of an attribute assigned to all entities can have differing values between entities. An example of an attribute in the above model is a patient's length of stay. Global variables are characteristics in the model that are the same for all entities. The total number of available beds at any one time can be considered a global variable because it is the same for all patients. Resources are items that are used by the entities. In the above model, the beds are resources. Queues form when entities have to wait to use a resource. If no beds are available, patients are sent elsewhere; thus, no queues are present in the above model. Again, events drive the changes in the simulation and are represented by patients' arrivals and departures in the DES model. Statistical accumulators record important information about the model's performance over time. Some statistical accumulators that could be applied to the above model at any given time are the total number of patients arriving at the unit; the number of patients admitted to the unit; the minimum, average, and maximum length of stay; and the average bed use.
Because of the stochastic nature of a simulation model, it is necessary to run the model many times and for a long time. The statistical information obtained from each run can then be analyzed to obtain summary statistics representing the model's overall performance. In Costa et al.
[13•], statistics concerning various output measures such as transfer and deferral rates, the number of beds in use, and the number of patient-days of care were gathered for several models testing various capacity levels (number of beds). The authors used these results in a discussion of the effects of increased capacity on these and other performance measures. Overall, the model provides an excellent example of the flexibility that DES affords the decision maker. For example, the model can be adjusted based on admission criteria, patient priorities, and distributions of length of stay for different case mixes of patients that are all specific to the individual critical care unit being studied.
Incorporating biology into discrete-event simulation
Discrete-event simulation can be used to model more than resource allocation models, because it represents clinical progression and health states remarkably well. Although not directly related to intensive care, there have been examples of DES models that have incorporated the biology of disease progression to evaluate policy making and patient treatment decisions. of the models allows for the testing of various policies to determine the best way to allocate organs.
Differences between these simulation methods
Although there are several similarities between these simulation methods, there are a few important differences, which are graphically described in Figure 1 . In a Markov cohort simulation, the entire cohort is represented in the model all at once, and calculations are made based on what portion of the cohort is found in each state. Transitions can depend only on the state the portion of the cohort is in; therefore, the only way to incorporate complex histories is to build intractably large models with many states. The Monte Carlo (sometimes called microsimulation) model is similar to the Markov cohort simulation except that only one member of the cohort is in the model at a time. This allows individual patient clinical characteristics and history to affect the probability of moving to a different state. DES is, in some sense, a mixture of the other two. A "real" or actual number of patients are in the model at once, but each individual is tracked, the individual's history is recorded, and the individual's interactions with other patients in the model (the development of queues, competition for resources) are incorporated.
Conclusion
Although simulation is not yet commonly used to evaluate clinical and health delivery scenarios in the intensive care unit, it has substantial promise to inform questions regarding intensive care that other methods are not well suited to investigate. The examples presented here provide an overview and introduction to the types of problems to which simulation has been applied.
